Doxepin Dosage and Usage Guidelines for Depression, Anxiety, and Insomnia
For insomnia, low-dose doxepin (3-6 mg) is recommended for sleep maintenance insomnia, while for major depressive disorder and anxiety disorders, higher doses (75-150 mg/day) are typically required, with careful titration based on response and tolerability. 1, 2
Dosage Recommendations by Indication
Insomnia
- Recommended dose: 3-6 mg taken at bedtime
- Evidence basis: American Academy of Sleep Medicine guidelines suggest doxepin as a treatment for sleep maintenance insomnia 1
- Mechanism: At low doses (1-6 mg), doxepin acts primarily as a selective H1 histamine receptor antagonist 3
- Advantage: Lower doses minimize anticholinergic and other side effects while maintaining sleep efficacy 3
- Clinical pearl: Low-dose doxepin significantly improves sleep latency compared to other agents after 8-12 weeks of treatment 4
Major Depressive Disorder
- Starting dose: 75 mg/day for most patients with mild to moderate depression
- Dose range: 75-150 mg/day is the usual optimum range
- Maximum dose: Up to 300 mg/day for severely ill patients, though additional benefit is rarely obtained above this dose 2
- Administration options:
- Can be given as divided doses or once daily
- If once daily, maximum recommended dose is 150 mg at bedtime 2
- Low-dose option: 25-50 mg/day may be sufficient for patients with very mild symptoms 2
- Onset of action: Anti-anxiety effects appear before antidepressant effects; optimal antidepressant effect may take 2-3 weeks 2
Anxiety Disorders
- Dosing: Similar to depression dosing (75-150 mg/day)
- Clinical consideration: Doxepin is more effective than benzodiazepines when anxiety is accompanied by significant depression 5
- Combination therapy: Low-dose doxepin (12.5 mg/day) has shown efficacy in comorbid insomnia and anxiety disorders 4
Special Populations
Elderly Patients
- Dosing: Start at lower doses (e.g., 25-50 mg/day) and titrate slowly
- Rationale: Elderly patients may have decreased renal function and are more susceptible to anticholinergic effects and sedation 2
- Monitoring: Observe closely for confusion, oversedation, and orthostatic hypotension 2
Patients with Hepatic/Renal Impairment
- Recommendation: Use lower doses and monitor closely
- Caution: The extent of renal excretion of doxepin has not been determined 2
Administration Guidelines
- Timing: For once-daily dosing, administer at bedtime to utilize the sedative properties
- Titration: Increase or decrease at appropriate intervals based on individual response
- Duration: For depression, continue treatment for at least 6 months after symptom resolution to prevent relapse
Side Effects and Monitoring
Common Side Effects
- Anticholinergic effects: Dry mouth, blurred vision, constipation, urinary retention
- CNS effects: Drowsiness (most common), confusion, disorientation
- Cardiovascular: Hypotension, hypertension, tachycardia (less common than with other tricyclics) 5
Monitoring Parameters
- Baseline: Complete blood count, liver function tests, ECG (especially in elderly or those with cardiovascular disease)
- Follow-up: Monitor for clinical response, side effects, and suicidality (especially in young adults)
Precautions and Contraindications
- Contraindicated in: Patients with glaucoma, urinary retention, or hypersensitivity to the drug 2
- Suicidality risk: Increased risk in children, adolescents, and young adults; not approved for pediatric use 2
- Drug interactions: May block antihypertensive effects of guanethidine at doses above 150 mg/day 2
Discontinuation
- Approach: Gradual tapering to avoid withdrawal symptoms
- Monitoring: Watch for rebound insomnia, which may occur in some patients 6
Clinical Decision Algorithm
- For insomnia alone: Start with 3 mg at bedtime, may increase to 6 mg if needed
- For depression or anxiety: Begin with 75 mg/day, assess response after 2-3 weeks
- If partial response: Increase to 150 mg/day
- If still inadequate response: May increase up to 300 mg/day in severe cases
- If side effects occur: Reduce dose or consider alternative medication
Doxepin's dual properties as an antidepressant at higher doses and a selective antihistamine at lower doses make it a versatile option for treating multiple conditions, but careful dose selection based on the specific indication is essential for optimizing outcomes while minimizing adverse effects.